Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
41 HKD | +1.36% | +15.73% | -16.09% |
Apr. 30 | Keymed Biosciences' Allergy Treatment NDA Accepted by NMPA | MT |
Apr. 29 | Keymed Biosciences Allergy Drug Achieves Phase III Clinical Trial End Points | MT |